Corcept Therapeutics | CORT - Przychody Ze Sprzedaży





Obroty Zmiana Data
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Alaunos Therapeutics USD 2K 2K 2025-03
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Ardelyx USD 94.47M 30.74M 2026-03
Aurora Cannabis CAD 38.01M 56.18M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Canopy Growth CAD 71.25M 3.29M 2026-03
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
J&J USD 24.1B 500M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Merck USD 16.29B 110M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pacira USD 177M 19.87M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
TG Therapeutics USD 194.8M 2.23M 2026-03